243 related articles for article (PubMed ID: 21748432)
1. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
3. CCN3, a key matricellular protein, distinctly inhibits TGFβ1-mediated Smad1/5/8 signalling in human podocyte culture.
Madne TH; Dockrell MEC
Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):5-10. PubMed ID: 29506624
[TBL] [Abstract][Full Text] [Related]
4. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
5. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
[TBL] [Abstract][Full Text] [Related]
6. Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.
Wu Q; Jorgensen M; Song J; Zhou J; Liu C; Pi L
Gastroenterol Res Pract; 2016; 2016():2313850. PubMed ID: 27829832
[TBL] [Abstract][Full Text] [Related]
7. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling.
Borkham-Kamphorst E; Schaffrath C; Van de Leur E; Haas U; Tihaa L; Meurer SK; Nevzorova YA; Liedtke C; Weiskirchen R
Biochim Biophys Acta; 2014 May; 1843(5):902-14. PubMed ID: 24487063
[TBL] [Abstract][Full Text] [Related]
8. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
[TBL] [Abstract][Full Text] [Related]
9. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
10. Proposal for a unified CCN nomenclature.
Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
[TBL] [Abstract][Full Text] [Related]
12. CCN2/CTGF promotes liver fibrosis through crosstalk with the Slit2/Robo signaling.
Pi L; Sun C; Jn-Simon N; Basha S; Thomas H; Figueroa V; Zarrinpar A; Cao Q; Petersen B
J Cell Commun Signal; 2023 Mar; 17(1):137-150. PubMed ID: 36469291
[TBL] [Abstract][Full Text] [Related]
13. The CCN family of genes: a perspective on CCN biology and therapeutic potential.
Yeger H; Perbal B
J Cell Commun Signal; 2007 Dec; 1(3-4):159-64. PubMed ID: 18568428
[TBL] [Abstract][Full Text] [Related]
14. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
15. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.
Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W
J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral CCN gene transfers induce in vitro and in vivo endoplasmic reticulum stress and unfolded protein response.
Borkham-Kamphorst E; Steffen BT; Van de Leur E; Tihaa L; Haas U; Woitok MM; Meurer SK; Weiskirchen R
Biochim Biophys Acta; 2016 Nov; 1863(11):2604-2612. PubMed ID: 27452908
[TBL] [Abstract][Full Text] [Related]
17. The CCN family: a new stimulus package.
Brigstock DR
J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
[TBL] [Abstract][Full Text] [Related]
18. Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2.
Leask A
J Cell Commun Signal; 2009 Jun; 3(2):161-2. PubMed ID: 19475498
[TBL] [Abstract][Full Text] [Related]
19. The CCN family of proteins: a 25th anniversary picture.
Perbal A; Perbal B
J Cell Commun Signal; 2016 Sep; 10(3):177-190. PubMed ID: 27581423
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.
Abd El Kader T; Kubota S; Janune D; Nishida T; Hattori T; Aoyama E; Perbal B; Kuboki T; Takigawa M
J Cell Commun Signal; 2013 Mar; 7(1):11-8. PubMed ID: 23065484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
